Decreased striatal RGS2 expression has been suggested to be neuroprotective in Huntington's disease (HD).44 A similar compensatory response may underlie the lower RGS2 expression observed in our AD LCLs (Figure 3a) and in postmortem AD brain tissues (Figures 4d–f). This evidence concerns the gene RGS2 and Alzheimer disease.